• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

4

CATEGORIES

  • 37
  • 13
  • 7
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

15
16
55
58

PUBLISHED

5
10
38
58

PRODUCT TYPE

43
15

Search "Seattle Genetics Inc-Therapeutic Competitors" returned 58 results.

PRODUCT TITLE

ZymoGenetics, Inc. - SWOT, Strategy and Corporate Finance Report

ZymoGenetics, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product...

January 2013
FROM

Seattle Genetics, Inc.

A textual analysis of the financial results for Seattle Genetics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio...

February 2015
FROM
Seattle Genetics, Inc. (SGEN) - Financial and Strategic Analysis Review Seattle Genetics, Inc. (SGEN) - Financial and Strategic Analysis Review - Product Thumbnail Image

Seattle Genetics, Inc. (SGEN) - Financial and Strategic Analysis Review

Seattle Genetics, Inc. (Seattle) is a biotechnology company engaged in the discovery and the development of monoclonal antibody-based drugs to treat cancer and autoimmune diseases. The company's lead...

August 2010
FROM
ZymoGenetics, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report ZymoGenetics, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report - Product Thumbnail Image

ZymoGenetics, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report

Synopsis ICD Research's "ZymoGenetics, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains...

February 2012
FROM
ZymoGenetics, Inc.: SWOT Analysis & Company Profile ZymoGenetics, Inc.: SWOT Analysis & Company Profile - Product Thumbnail Image

ZymoGenetics, Inc.: SWOT Analysis & Company Profile

Synopsis Business Review’s ZymoGenetics, Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company. Summary This SWOT Analysis...

September 2010
FROM

Acorda Therapeutics, Inc.

A textual analysis of the financial results for Acorda Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

February 2015
FROM
ZymoGenetics, Inc. (ZGEN) - Financial and Strategic Analysis Review ZymoGenetics, Inc. (ZGEN) - Financial and Strategic Analysis Review - Product Thumbnail Image

ZymoGenetics, Inc. (ZGEN) - Financial and Strategic Analysis Review

ZymoGenetics, Inc. (ZymoGenetics) is a biotechnology company principally engaged in the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases....

August 2010
FROM

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015 Summary This, ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015’, provides an overview of the Anaplastic Large Cell...

January 2015
FROM

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014 Summary This, ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014’, provides an overview of the Anaplastic Large Cell...

December 2014
FROM
Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015 Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015 - Product Thumbnail Image

Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015

Non-Hodgkin’s Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015 Summary GlobalData, the industry analysis specialist, has released a new report on the Pharmaceutical and Healthcare...

January 2010
FROM

Mycosis Fungoides - Pipeline Review, H1 2014

Mycosis Fungoides - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Mycosis Fungoides - Pipeline Review, H1 2014’, provides an overview of the Mycosis Fungoides’s therapeutic pipeline. This...

May 2014
FROM

Mycosis Fungoides - Pipeline Review, H2 2014

Mycosis Fungoides - Pipeline Review, H2 2014 Summary This, ‘Mycosis Fungoides - Pipeline Review, H2 2014’, provides an overview of the Mycosis Fungoides’s therapeutic pipeline. This report provides...

October 2014
FROM

NPS Pharmaceuticals, Inc.

A textual analysis of the financial results for NPS Pharmaceuticals, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

February 2015
FROM

PDL Biopharma, Inc.

A textual analysis of the financial results for PDL Biopharma, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio...

February 2015
FROM

Hodgkin Lymphoma - Pipeline Review, H1 2014

Hodgkin Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hodgkin Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Hodgkin Lymphoma’s therapeutic pipeline. This...

February 2014
FROM

Techne Corporation

A textual analysis of the financial results for Techne Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses...

November 2014

Hodgkin Lymphoma - Pipeline Review, H1 2015

Hodgkin Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Hodgkin Lymphoma’s therapeutic pipeline. This report provides...

January 2015
FROM

T-Cell Lymphomas - Pipeline Review, H2 2014

T-Cell Lymphomas - Pipeline Review, H2 2014 Summary This, ‘T-Cell Lymphomas - Pipeline Review, H2 2014’, provides an overview of the T-Cell Lymphomas’s therapeutic pipeline. This report provides...

October 2014
FROM

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2014

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2014’, provides an overview of the Anaplastic...

June 2014
FROM

ImmunoGen, Inc. (IMGN) - Financial and Strategic SWOT Analysis Review

ImmunoGen, Inc. (IMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

January 2014
FROM
Loading Indicator

Our Clients

Hewlett-Packard Company Microsoft Corporation Philips N.V. SONY Corporation Cypress Semiconductor Corporation Panasonic Corporation